The IBN SINA Pharmaceutical Industry PLC (DSE: IBNSINA)
Bangladesh
· Delayed Price · Currency is BDT 291.80
-6.40 (-2.15%)
At close: Nov 14, 2024
IBNSINA Cash Flow Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Net Income | - | - | - | 605.87 | 489.12 | 392.53 | Upgrade
|
| Depreciation & Amortization | 862.64 | 862.64 | 764.54 | 223.93 | 215.86 | 173.17 | Upgrade
|
| Loss (Gain) From Sale of Assets | 7.26 | 7.26 | 11.15 | - | 1.22 | - | Upgrade
|
| Loss (Gain) on Equity Investments | -5.87 | -5.87 | -11.91 | 1.29 | 1.93 | 1.79 | Upgrade
|
| Other Operating Activities | -37.93 | -37.93 | 52.15 | -61.17 | -0.06 | 21.66 | Upgrade
|
| Change in Accounts Receivable | -46.97 | -46.97 | -66.51 | -26.55 | -1.93 | -2.76 | Upgrade
|
| Change in Inventory | -328.6 | -328.6 | -3.15 | -225.4 | -138.78 | -120.68 | Upgrade
|
| Change in Accounts Payable | -6.11 | -6.11 | 141.75 | -95.77 | -10.05 | 35.28 | Upgrade
|
| Change in Other Net Operating Assets | -5.55 | -5.55 | 10.16 | -3.62 | -5.14 | -3.43 | Upgrade
|
| Operating Cash Flow | 438.88 | 438.88 | 898.18 | 418.56 | 552.17 | 497.55 | Upgrade
|
| Operating Cash Flow Growth | -51.14% | -51.14% | 114.59% | -24.20% | 10.98% | 14.81% | Upgrade
|
| Capital Expenditures | -613.51 | -613.51 | -425.19 | -365.16 | -242.53 | -612.49 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.42 | 0.42 | 2.55 | - | 1.43 | 0.68 | Upgrade
|
| Investment in Securities | -317 | -317 | -196.36 | 60 | -3 | -20 | Upgrade
|
| Other Investing Activities | 2.84 | 2.84 | 2.51 | 2.86 | 2.07 | 0.92 | Upgrade
|
| Investing Cash Flow | -927.24 | -927.24 | -616.49 | -302.3 | -242.03 | -630.89 | Upgrade
|
| Short-Term Debt Issued | 717.72 | 717.72 | - | 159.44 | - | 128.37 | Upgrade
|
| Long-Term Debt Issued | 78.92 | 78.92 | - | - | 171.7 | 122.01 | Upgrade
|
| Total Debt Issued | 796.64 | 796.64 | - | 159.44 | 171.7 | 250.38 | Upgrade
|
| Short-Term Debt Repaid | - | - | -137.72 | - | -272.31 | - | Upgrade
|
| Long-Term Debt Repaid | - | - | -37.92 | -51.61 | - | - | Upgrade
|
| Total Debt Repaid | - | - | -175.64 | -51.61 | -272.31 | - | Upgrade
|
| Net Debt Issued (Repaid) | 796.64 | 796.64 | -175.64 | 107.82 | -100.61 | 250.38 | Upgrade
|
| Common Dividends Paid | -179.9 | -179.9 | -178.52 | -177.39 | -131.51 | -86.98 | Upgrade
|
| Other Financing Activities | - | - | - | 17.5 | 3.5 | 0 | Upgrade
|
| Financing Cash Flow | 616.74 | 616.74 | -354.16 | -52.07 | -228.62 | 163.4 | Upgrade
|
| Foreign Exchange Rate Adjustments | 7.26 | 7.26 | 11.15 | -2.83 | -0.2 | -1.09 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | 0 | 0 | - | - | Upgrade
|
| Net Cash Flow | 135.64 | 135.64 | -61.32 | 61.37 | 81.32 | 28.96 | Upgrade
|
| Free Cash Flow | -174.62 | -174.62 | 472.99 | 53.4 | 309.64 | -114.94 | Upgrade
|
| Free Cash Flow Growth | - | - | 785.74% | -82.75% | - | - | Upgrade
|
| Free Cash Flow Margin | -1.54% | -1.54% | 5.18% | 0.63% | 4.20% | -1.86% | Upgrade
|
| Free Cash Flow Per Share | -5.59 | -5.59 | 15.14 | 1.71 | 9.91 | -3.68 | Upgrade
|
| Cash Interest Paid | 47.77 | 47.77 | 36.61 | 40.94 | 38.76 | 31.47 | Upgrade
|
| Cash Income Tax Paid | 188.9 | 188.9 | 131.83 | 216.77 | 186.64 | 148.71 | Upgrade
|
| Levered Free Cash Flow | 269.37 | 269.37 | 870.9 | 12.31 | 230.82 | -162.78 | Upgrade
|
| Unlevered Free Cash Flow | 302.86 | 302.86 | 898.67 | 41.89 | 255.82 | -140.96 | Upgrade
|
| Change in Net Working Capital | 517.88 | 517.88 | -46.94 | 330.09 | 175.58 | 76.2 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.